Qu, Youge
Shan, Jiajing
Wang, Siming
Chang, Lijia
Pu, Yaoyu
Wang, Xingming
Tan, Yunfei
Yamamoto, Masayuki
Hashimoto, Kenji http://orcid.org/0000-0002-8892-0439
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP20dm0107119)
Article History
Received: 13 September 2020
Accepted: 27 October 2020
First Online: 12 November 2020
Compliance with ethical standards
:
: Dr. Hashimoto is an inventor on a filed patent application on “The use of <i>R</i>-ketamine in the treatment of psychiatric diseases” by Chiba University. Other authors have no conflicts of interest.